New Novartis Health Technology Accelerator Program for Manchester, UK
Novartis this week announced the launch of the Greater Manchester (UK) Future of Health Challenge and named the start-up businesses selected to participate. The intensive 12-week program will include training, mentoring, and support from leaders in the health and technology space to create new clinical solutions for patients in Greater Manchester and beyond. Fifteen participants were selected from over 100 applicants who replied to the call for creative use of new technologies to solve some of Greater Manchester’s most pressing health problems. In addition to access to world-class support and expertise, participating start-up companies also have a chance to receive cloud space and additional expert support from Google Cloud for Startups. Developmental projects entering the program range from advanced visualization software and tools to help improve cognition, to home-based care systems that support elderly independent living and a remote thermometer which requires no contact with the patient. The program asked applicant health technology start-ups and entrepreneurs to submit ideas that could be beneficial to one or more of three focus areas as selected by local health leaders: • Solutions that improve the experience of those with Dementia and/or Frailty. • Solutions allowing primary care and outpatient services to be delivered in or near the home for patients. • Innovations to allow Digital Nudges to improve Prevention and Public Health. The program's fifteen participants are:
- BuddyHub
- Cievert
- Collabco
- Evergreen Life
- Flock
- Gendius
- GiveVision
- Healum
- Holovis
- Howz
- ImproveWell
- Konsie
- Mind Moose
- My Cognition
- TriMedika
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
